CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income (loss)	$ (81,966)	$ 13,706
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	6,035	5,435
Amortization of inventory step-up	2,537	0
Inventory impairment charges	31	503
Share-based compensation	11,395	12,415
Amortization of discount and cost of issuance of debt	259	0
Bad debts	0	24
(Gain) loss from change in fair value of warrants	47,332	(47,353)
(Gain) loss from change in fair value of contingent considerations and acquisition-related holdbacks	1,630	(83)
Deferred City Semi compensation	0	125
Deferred tax liabilities	(3,716)	0
Amortization of right-of-use assets	525	469
Unrealized foreign currency transaction (gain) loss	0	(14)
Changes in operating assets and liabilities:
Accounts receivable	4,823	(1,796)
Inventory	(9,973)	(235)
Accounts payable	(2,937)	1,271
Accrued expenses and other current liabilities	(1,562)	1,037
Accrued payroll liabilities	269	(1,820)
Deferred revenue	(523)	1,792
Prepaid and other current assets	(5,627)	(789)
Operating lease liabilities	(453)	(144)
Other long-term liabilities	(964)	(257)
Net cash used in operating activities	(32,885)	(15,714)
Cash flows from investing activities:
Purchases of property and equipment	(3,199)	(565)
Business combinations, net of cash acquired	(98,429)	(8,705)
Net cash used in investing activities	(101,628)	(9,270)
Cash flows from financing activities:
Proceeds from issuance of common stock/At-the-market offering	34,194	0
Proceeds from issuance of debt obligations	747	315
Payments on debt obligations	(11,825)	(383)
Payments on financed software	(2,069)	(704)
Proceeds from exercise of stock options	19	52
Net cash provided by (used in) financing activities	21,066	(720)
Effect of exchange rate changes on cash and cash equivalents	(1,034)	(398)
Net decrease in cash and cash equivalents	(114,481)	(26,102)
Cash, cash equivalents and restricted cash at beginning of period	321,879	219,464
Cash, cash equivalents and restricted cash at end of period	207,398	193,362
Supplemental disclosure of cash flow information:
Cash paid for interest	88	58
Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment, accrued but not paid	348	39
Fair value of common stock issued for business combination	85,391	0
Fair value of common stock issuable for business combination	20,979	0
Contingent consideration for business combination	73,047	8,204
Accrual for purchase consideration for business combination	$ 4,264	$ 9,674